← All trials
NCT06176027
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 30, 2023
- Primary completion
- Sep 1, 2028
- Completion date
- Sep 1, 2030
- First posted
- Dec 19, 2023
- Last posted
- Dec 19, 2023
- Enrollment
- 52
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Government of ChinaLead sponsor
- Government of ChinaReponsible party - principal investigator
- Government of ChinaStudy chair
- People's Liberation Army of ChinaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.